North America Infant, Child, and Maternal Probiotic Supplements Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Form (Capsules and Soft Gels, Gummies, Liquid, and Others) and End User (Infant and Toddler, Children, and Maternal Women)

No. of Pages: 104    |    Report Code: BMIRE00027153    |    Category: Consumer Goods

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Infant, Child, and Maternal Probiotic Supplements Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Infant, Child, and Maternal Probiotic Supplements Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Infant, Child, and Maternal Probiotic Supplements Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in awareness about gut health
  • 5.1.2 Rising incidence of digestive issues in children
  • 5.1.3 Growth in organic supplement demand
5.2 Market Opportunities
  • 5.2.1 Rising demand for vegan and natural supplements
  • 5.2.2 Expansion in emerging markets
  • 5.2.3 Growth in healthcare partnerships and collaborations
5.3 Future Trends
  • 5.3.1 Development of multi-strain probiotic formulas
  • 5.3.2 Use of personalized nutrition in supplements
  • 5.3.3 Increasing focus on sustainable packaging
5.4 Impact of Drivers and Restraints

6. North America Infant, Child, and Maternal Probiotic Supplements Market Regional Analysis

6.1 North America Infant, Child, and Maternal Probiotic Supplements Market Overview
6.2 North America Infant, Child, and Maternal Probiotic Supplements Market Revenue 2020-2028 (US$ Million)
6.3 North America Infant, Child, and Maternal Probiotic Supplements Market Forecast Analysis

7. North America Infant, Child, and Maternal Probiotic Supplements Market Analysis – by Form

7.1 Capsules and Soft Gels
  • 7.1.1 Overview
  • 7.1.2 Capsules and Soft Gels: North America Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Gummies
  • 7.2.1 Overview
  • 7.2.2 Gummies: North America Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Liquid
  • 7.3.1 Overview
  • 7.3.2 Liquid: North America Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Infant, Child, and Maternal Probiotic Supplements Market Analysis – by End User

8.1 Infant and Toddler
  • 8.1.1 Overview
  • 8.1.2 Infant and Toddler: North America Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Children
  • 8.2.1 Overview
  • 8.2.2 Children: North America Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Maternal Women
  • 8.3.1 Overview
  • 8.3.2 Maternal Women : North America Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Infant, Child, and Maternal Probiotic Supplements Market – North America Analysis

9.1 North America
  • 9.1.1 North America Infant, Child, and Maternal Probiotic Supplements Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 9.1.1.1 North America Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 US: North America Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.1.1 US: North America Infant, Child, and Maternal Probiotic Supplements Market Breakdown, by Form
    • 9.1.1.1.2 US: North America Infant, Child, and Maternal Probiotic Supplements Market Breakdown, by End User
  • 9.1.1.2 Canada: North America Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.2.1 Canada: North America Infant, Child, and Maternal Probiotic Supplements Market Breakdown, by Form
    • 9.1.1.2.2 Canada: North America Infant, Child, and Maternal Probiotic Supplements Market Breakdown, by End User
  • 9.1.1.3 Mexico : North America Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.3.1 Mexico : North America Infant, Child, and Maternal Probiotic Supplements Market Breakdown, by Form
    • 9.1.1.3.2 Mexico : North America Infant, Child, and Maternal Probiotic Supplements Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. North America Infant, Child, and Maternal Probiotic Supplements Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Bayer Corporation
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 MaryRuth Organics, LLC
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Mommy’s Bliss Inc.
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Pharmavite LLC
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Nestlé S.A.
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 BioGaia AB
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Evolve
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 Biosystems
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 Lovebug
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
12.10 Probiotics
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments
12.11 Biomeology
  • 12.11.1 Key Facts
  • 12.11.2 Business Description
  • 12.11.3 Products and Services
  • 12.11.4 Financial Overview
  • 12.11.5 SWOT Analysis
  • 12.11.6 Key Developments
12.12 Nordic Naturals
  • 12.12.1 Key Facts
  • 12.12.2 Business Description
  • 12.12.3 Products and Services
  • 12.12.4 Financial Overview
  • 12.12.5 SWOT Analysis
  • 12.12.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - North America Infant, Child, and Maternal Probiotic Supplements Market

  1.  Bayer Corporation                                           
  2. MaryRuth Organics, LLC                                 
  3. Mommy’s Bliss Inc.                                          
  4. Pharmavite LLC                                                  
  5. Nestlé S.A.                                                           
  6. BioGaia AB                                                           
  7. Evolve
  8.  Biosystems                                            
  9. Lovebug
  10. Probiotics                                           
  11. Biomeology   
  12. Nordic Naturals